|
CGTX Cognition Therapeutics Inc 1455365 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-3,932,000.00 |
| Balance Sheet |
|
Current Assets
|
$38,299,000.00 |
|
Assets
|
$38,896,000.00 |
|
Current Liabilities
|
$5,450,000.00 |
|
Liabilities
|
$5,872,000.00 |
|
Equity
|
$33,024,000.00 |
|
Shares Out
|
95055773.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,595,000.00 |
|
Investing Cash Flow
|
$-20,000.00 |
| Market Analysis |
Market Cap
|
$91,253,542.08 |
|
Price
|
$0.96 |
|
BVPS
|
0.35 |
|
PB
|
2.74 |
|
EPS
|
-0.04 |
|
FCF
|
$-8,615,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:50 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:40 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.11 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CGTX documents filed with the SEC.
CGTX Filings
Clear
